MO
57
4
IFF
62
5
BK
77
2
HBAN
82
2
EXC
53
3
MMC
60
3
NWL
57
3
LH
48
2
CPB
37
2
ALLE
48
2
NKE
36
6
PG
43
2
ES
50
3
HSY
50
5
GRMN
40
3
AZO
46
-2
F
58
2
GS
78
2
OMC
55
-7
MU
79
3
MO
57
4
IFF
62
5
BK
77
2
HBAN
82
2
EXC
53
3
MMC
60
3
NWL
57
3
LH
48
2
CPB
37
2
ALLE
48
2
NKE
36
6
PG
43
2
ES
50
3
HSY
50
5
GRMN
40
3
AZO
46
-2
F
58
2
GS
78
2
OMC
55
-7
MU
79
3
Financhill
Back

Silence Therapeutics Plc 10K Form

Sell
32

SLN
Silence Therapeutics Plc

Last Price:
$6.18
Seasonality Move:
-4.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLN News And Ratings

See the #1 stock for the next 7 days that we like better than SLN

SLN Financial Statistics

Sales & Book Value

Annual Sales: $43.3M
Cash Flow: $-10.8M
Price / Cash Flow: 0
Annual Sales: $1.57
Price / Book: 3.92

Profitability

EPS (TTM): -2.37950
Net Income (TTM): $-112.3M
Gross Margin: $31.2M
Return on Equity: -102.07%
Return on Assets: -58.29%

Silence Therapeutics Plc Earnings Forecast

Key Silence Therapeutics Plc Financial Ratios

  • The Gross Profit Margin over the past 31 years for SLN is 72.10%.
  • The Selling, General & Administrative Expenses for SLN have been equal to 62.15% of Gross Profit Margin.
  • The Research & Development expenses have been 125.17% of Revenue.
  • The Net Earning history of SLN is -104.74% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 12 years.

Silence Therapeutics Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SLN
Website: silence-therapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.69
Quick Ratio: 5.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLN Technical Analysis vs Fundamental Analysis

Sell
32
Silence Therapeutics Plc (SLN) is a Sell

Is Silence Therapeutics Plc a Buy or a Sell?